These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 32492158)
1. New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT. Elfeky R; Lucchini G; Lum SH; Ottaviano G; Builes N; Nademi Z; Battersby A; Flood T; Owens S; Cant AJ; Young H; Greener S; Walsh P; Kavanagh D; Annavarapu S; Rao K; Amrolia P; Chiesa R; Worth A; Booth C; Skinner R; Doncheva B; Standing J; Gennery AR; Qasim W; Slatter M; Veys P Blood Adv; 2020 Jun; 4(11):2418-2429. PubMed ID: 32492158 [TBL] [Abstract][Full Text] [Related]
2. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease. Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323 [TBL] [Abstract][Full Text] [Related]
3. Incidence and Role of Recipient-Specific Antibodies in Allogeneic Hematopoietic Cell Transplantation from Mismatched Related Donors. Sadowska-Klasa A; Dukat-Mazurek A; Zielińska H; Dębska-Zielkowska J; Piekarska A; Moszkowska G; Mensah-Glanowska P; Zaucha JM Transplant Cell Ther; 2024 Jan; 30(1):99.e1-99.e10. PubMed ID: 37875214 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus. Labrador J; López-Corral L; López-Godino O; Vázquez L; Cabrero-Calvo M; Pérez-López R; Díez-Campelo M; Sánchez-Guijo F; Pérez-López E; Guerrero C; Alberca I; Del Cañizo MC; Pérez-Simón JA; González-Porras JR; Caballero D Bone Marrow Transplant; 2014 May; 49(5):684-90. PubMed ID: 24566710 [TBL] [Abstract][Full Text] [Related]
5. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation. Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271 [TBL] [Abstract][Full Text] [Related]
6. Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation-A secondary CIBMTR analysis. Schoettler ML; Westbrook A; Watkins B; Stenger E; Qayed M; Chonat S; Williams KM Br J Haematol; 2024 Jul; 205(1):243-255. PubMed ID: 38817006 [TBL] [Abstract][Full Text] [Related]
7. Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis. Shayani S; Palmer J; Stiller T; Liu X; Thomas SH; Khuu T; Parker PM; Khaled SK; Forman SJ; Nakamura R Biol Blood Marrow Transplant; 2013 Feb; 19(2):298-304. PubMed ID: 23078784 [TBL] [Abstract][Full Text] [Related]
8. [The risk factors and prognosis of transplant-associated thrombotic microangiopathy following acute graft-versus-host disease]. Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ Zhonghua Nei Ke Za Zhi; 2013 Feb; 52(2):156-60. PubMed ID: 23967613 [TBL] [Abstract][Full Text] [Related]
10. Increased Body Mass Index Augments Endothelial Injury and Clinical Outcomes after Hematopoietic Stem Cell Transplantation. Koo J; Ziady AG; Reynaud D; Abdullah S; Luebbering N; Kahn S; Langenberg L; Strecker L; Lake K; Dandoy CE; Lane A; Myers KC; Sabulski A; Good S; Nalapareddy K; Solomon M; Siefert ME; Skala E; Jodele S; Davies SM Transplant Cell Ther; 2023 Nov; 29(11):704.e1-704.e8. PubMed ID: 37625594 [TBL] [Abstract][Full Text] [Related]
11. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome. Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931 [TBL] [Abstract][Full Text] [Related]
12. A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD. Furukawa M; Wang X; Ohkawara H; Fukatsu M; Alkebsi L; Takahashi H; Harada-Shirado K; Shichishima-Nakamura A; Kimura S; Ogawa K; Ikezoe T Blood Adv; 2019 Jul; 3(14):2128-2143. PubMed ID: 31300420 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis. Luo L; Xiong H; Chen Z; Yang L; Sun M; Lu W; Tao F; Wang Z; Li J; Li Z; Tang S Clin Transl Oncol; 2023 Aug; 25(8):2451-2461. PubMed ID: 36973479 [TBL] [Abstract][Full Text] [Related]
14. Neurologic Complications of the Central Nervous System after Allogeneic Stem Cell Transplantation: The Role of Transplantation-Associated Thrombotic Microangiopathy as a Potential Underreported Cause. Sala E; Neagoie AM; Lewerenz J; Saadati M; Benner A; Gantner A; Wais V; Döhner H; Bunjes D Transplant Cell Ther; 2024 Jun; 30(6):586.e1-586.e11. PubMed ID: 38508452 [TBL] [Abstract][Full Text] [Related]
15. Intrapatient variability in concentration/dose ratio of tacrolimus predicts transplant-associated thrombotic microangiopathy. Sagou K; Fukushima N; Ukai S; Goto M; Ozeki K; Kohno A Int J Hematol; 2021 Jan; 113(1):63-72. PubMed ID: 32876853 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for transplant-associated thrombotic microangiopathy (TA-TMA): a systematic review and meta-analysis. Guo M; Qi J; Hou Q; Li X; Han Y Expert Rev Hematol; 2023 Mar; 16(3):191-203. PubMed ID: 36588482 [TBL] [Abstract][Full Text] [Related]
17. Acute graft-versus-host disease increase risk and accuracy in prediction model of transplantation-associated thrombotic microangiopathy in patients with myelodysplastic syndrome. Zhang Z; Wang H; Qi J; Tang Y; Cai C; Zhou M; Pan T; Wu D; Han Y Ann Hematol; 2022 Jun; 101(6):1295-1309. PubMed ID: 35357522 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort. Schoettler M; Lehmann LE; Margossian S; Lee M; Kean LS; Kao PC; Ma C; Duncan CN Blood Adv; 2020 Jun; 4(11):2536-2547. PubMed ID: 32516415 [TBL] [Abstract][Full Text] [Related]
20. Late transplant-associated thrombotic microangiopathy verified in bone marrow biopsy specimens is associated with chronic GVHD and viral infections. Hill W; Sotlar K; Hautmann A; Kolb HJ; Ullmann J; Hausmann A; Schmidt M; Tischer J; Pham TT; Rank A; Hoechstetter MA Eur J Haematol; 2024 May; 112(5):819-831. PubMed ID: 38243840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]